Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Abortion Drugs topic
No spam. Unsubscribe anytime.
Senate approves restrictions on dispensing of abortion drugs after extensive debate
Summary
House File 27 88, which tightens definitions, requires in‑person consultation and restricts dispensing of abortion‑inducing drugs, passed the Iowa Senate after extended floor debate featuring medical testimony, questions about data sources, and concerns about access in rural areas.
Get email alerts on the Abortion Drugs topic
No spam. Unsubscribe anytime.
The Iowa Senate voted to pass House File 27 88, a bill that revises the statutory definition of abortion, imposes in‑person consultation requirements and restricts dispensing of abortion‑inducing medications outside licensed facilities.
Sponsor Senator Schultz said the bill updates definitions, strengthens informed‑consent requirements and limits dispensing to licensed providers and facilities. In opening remarks he cited a claims‑analysis study he said showed a near 11 percent rate of serious adverse events in some insurance‑claims data; when pressed on the floor he did not produce a peer‑reviewed citation for that number.
Several senators pressed the sponsor on technical details. Senator Dre asked for the bill’s definition of a “required exam”; Senator Schultz said the bill requires an in‑person consultation but does not specify a particular exam. A physician who addressed the chamber through a senator read a written statement warning that the bill would “tie the hands of physicians” and could increase maternal morbidity and mortality by restricting treatment options.
Opponents emphasized access concerns. Senator Weiner said telemedicine and mail‑order medication are lifelines for many Iowans, particularly in rural areas facing OB‑GYN shortages, and argued the bill would create additional barriers to care. Senator Walz cited FDA approvals and statements from national medical organizations, saying mifepristone has been approved and reviewed by the FDA for more than two decades and is safe when used as indicated.
Supporters said the bill protects patients from unregulated online dispensing and requires screening for coercion; Senator Westrich argued patients should receive medications from trained medical professionals in licensed settings.
The sponsor moved final reading and the Senate voted to pass House File 27 88. The clerk recorded the roll as 30 ayes and 11 nays on the transcript; the chair declared the bill passed and the title agreed to and ordered the bill messaged to the House.
What happens next: With passage in the Senate the bill will be messaged to the House; floor debate highlighted sharply divided views about medical safety, telehealth access and the evidentiary basis cited by the sponsor.
